对人类iPSC衍生的软骨进行长期评估,以修复状缺陷
Yangfan Lu1,2, Elizabeth R Kats1,3, Sophie E Hines1,3
1Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
NPJ Regenerative medicine
|December 24, 2025
概括
诱导多能干细胞 (iPSCs) 与介质细胞干细胞 (MSCs) 相比,提供优越的质软骨再生. 长期研究表明,iPSC衍生细胞维持软骨基质并避免退化,证明软骨修复是安全的.
科学领域:
- 再生医学是一种再生医学.
- 干细胞生物学 干细胞生物学
- 整形外科的研究研究.
背景情况:
- 介质细胞 stromal 细胞 (MSCs) 用于软骨修复,但它们的长期疗效是有争议的.
- 诱导多能干细胞 (iPSCs) 在软骨再生方面表现有前途.
- 之前的研究缺乏对用于软骨修复的iPSC衍生细胞的长期评估.
研究的目的:
- 为了比较人类iPSC衍生的多能原生细胞 (iMPCs) 与人类MSCs的长期基生成和疗效.
- 评估iMPCs在长时间内修复质软骨的安全性和有效性.
主要方法:
- 长期的IMPC和MSC体外基生成 (8周).
- 分析与缩相关的基因表达 (例如,X型原体).
- 在体内动物研究评估在植入后12周和48周的软骨矩阵维护.
主要成果:
- 与MSC相比,iMPCs在体外表现出与缩相关基因的显著较低表达.
- 在12周和48周,iMPC植入物保持了比MSC植入物更多的软骨矩阵.
- 在48周的MSC组中观察到本地软骨围绕缺陷的严重退化,但在iMPC组中没有.
结论:
- 人类iPSC衍生的多能原生细胞 (iMPC) 是长期修复质软骨的安全有效细胞来源.
- 与MSC相比,iMPC表现出优越的长期矩阵维护和安全概况.
- 这些发现支持iMPCs在软骨缺陷的再生医学中的临床潜力.
相关概念视频
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...